00074-0282 DECNUPAZ - CanMED: NDC

Product NDC:

00074-0282

Brand Name:

DECNUPAZ

Generic Name:

Pivekimab sunirine-pvzy

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: PIVEKIMAB SUNIRINE

Strength: 2.0

Unit: mg/mL

Packages:

Code: 00074-0282-02

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-0282-02) / 1.15 mL in 1 VIAL, SINGLE-DOSE

Effective Date: May 27, 2026

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Drug Antibody Conjugate

Minor Class:

CD123

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox